Colivelin – 1 mg

Brand:
Cayman
CAS:
867021-83-8
Storage:
-20
UN-No:
Non-Hazardous - /

Colivelin is a potent synthetic peptide activator of STAT3 that has neuroprotective activity.{41809,41811} It protects approximately 50 and 100% of mouse primary cortical neurons from cell death induced by amyloid β (1-43) (Aβ43) when used at concentrations of 10 and 100 fM, respectively.{41809} Colivelin protects against cell death induced by V642I-APP in a CaM kinase IV (CaMKIV) and STAT3-dependent manner. It increases STAT3 phosphorylation in vitro and in vivo, an effect that correlates with improvements in working memory.{41811} Colivelin (10 pmol every six days) rescues deficits in spatial working memory in a mouse model of Alzheimer’s disease induced by intracerebroventricular injection of Aβ25-35. It also improves motor performance and prolongs survival in a mouse model of amyotrophic lateral sclerosis (ALS).{41810}  

 

Available on backorder

SKU: 24239 - 1 mg Category:

Description

A potent STAT3 activator and neuroprotective agent; protects approximately 50 and 100% of mouse primary cortical neurons from Aβ1-43-induced cell death at 10 and 100 fM, respectively; protects against V642I-APP-induced cell death in a CaMKIV and STAT3-dependent manner; It increases STAT3 phosphorylation in vitro and in vivo; rescues spatial working memory deficits in a mouse model of Alzheimer’s disease at 10 pmol every six days


Formal name: L-seryl-L-alanyl-L-leucyl-L-leucyl-L-arginyl-L-seryl-L-isoleucyl-L-prolyl-L-alanyl-L-prolyl-L-alanylglycyl-L-alanyl-L-seryl-L-arginyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-threonylglycyl-L-α-glutamyl-L-isoleucyl-L-α-aspartyl-L-leucyl-L-proline

Synonyms: 

Molecular weight: 2,645.10

CAS: 867021-83-8

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Peptides||Product Type|Biochemicals|Small Molecule Activators|Transcription Factors & Coactivators||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease||Research Area|Neuroscience|Neuroprotection